The largest database of trusted experimental protocols

Genotyping console

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Genotyping Console is a laboratory instrument designed to automate the genotyping process. It provides a standardized and efficient platform for analyzing genetic variations within samples. The core function of the Genotyping Console is to perform high-throughput genotyping analysis, enabling researchers to accurately determine the genetic makeup of their samples.

Automatically generated - may contain errors

57 protocols using genotyping console

1

High-Throughput SNP Genotyping and Copy Number Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was amplified and fragmented using a core SNP 6 reagent kit and DNase I (Affymetrix). Then the sample is hybridized onto Affymetrix GeneChip® genome-wide human SNP array 6.0 arrays and the arrays were scanned on an Affymetrix GeneChip® scanner 3000 7G. Data was initially analyzed on the Affymetrix Genotyping Console™ and subject to further in-house analysis. Raw CEL data of SNP 6.0 arrays was processed on the Genotyping Console (version 4.1.1.834, Affymetrix). Segment summary of each sample was generated by the Genotyping Console with default configuration. Then all summaries were processed by a proprietary algorithm to retrieve HUGO gene symbols of genes that are located within the segments regions, with copy number status and gene annotations.
+ Open protocol
+ Expand
2

Genome-Wide SNP Profiling of Migraine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood samples from patients with migraine were isolated in 5-mL EDTA vacutainers (BD, Plymouth, UK). Genomic DNA was extracted using the QIAamp DSP DNA Mini Kit on the QIAsymphony platform (Qiagen, Hilden, Germany). DNA quality was measured using a NanoDrop One spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The DNA samples were applied to the Affymetrix Axiom Genome-Wide TWB 2.0 arrays, which contain approximately 752,921 probes for a total of 686,463 SNPs. Among these SNPs, approximately 446,000 SNPs are associated with the characteristics of background genotypes in Taiwanese; approximately 105,000 SNPs are clinically relevant, whereas the rest are associated with disease features, drug response, and metabolism. The signal CEL files generated from the Axiom TWB 2.0 SNP array were transformed to genotyping data (tped and tfam files) using a Genotyping Console (Affymetrix).
+ Open protocol
+ Expand
3

Somatic Lesion Identification by SNP Arrays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Technical details regarding sample procession for SNP array assays were previously described (Maciejewski et al., 2009 (link), Gondek et al., 2008 (link)). The Gene Chip Mapping 250K Assay kit and the Genome-Wide Human SNP Array 6.0 (Affymetrix) were used. A stringent algorithm was applied for the identification of lesions using SNP arrays. Individuals with lesions identified by SNP array concordant with those identified in metaphase cytogenetics or typical lesions known to be recurrent required no further analysis. Changes reported in our internal or publicly available (Database of Genomic Variants; http://projects.tcag.ca/variation) copy number variation (CNV) databases were considered non-somatic and were excluded. Results were analyzed using CNAG (v3.0) (Nannya et al., 2005 (link)) or Genotyping Console (Affymetrix). All other lesions were confirmed as somatic or germline by analysis of CD3-sorted cells (Tiu et al., 2009 (link)).
+ Open protocol
+ Expand
4

Affymetrix Copy Number Analysis Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
Raw image files were converted into CEL-files by Affymetrix® genotyping console, which were then processed with the Affymetrix Power Tools (APT) apt-copynumber-workflow v 1.67. The values for contrastQC (based on Affymetrix® GTC 3.0.1 User Manual) and MAPD were extracted and samples that failed default QC values were discarded (MAPD > 0.4 and/or contrastQC < 0.4). For the remaining samples an identity by state (IBS) and principal component analysis (PCA) was performed as described previously [17 (link)]. The output of apt-copynumber-workflow was used as the input file for our in-house developed CNV data mining tool “CNVineta” [27 (link)]. A preliminary batch-wise filtering was performed based on the number of called CNVs per samples. Outliers were defined as samples which had more CNVs than the 75 % quantile plus 1.5 fold of the interquantile range. A rigorous manual raw data inspection for identifying false-negative and -positive CNVs was done subsequently. For the whole data mining process, the predicted CNVs with less than five supporting probes per CNV and mean probe set distance less than one kilobase, were ignored.
+ Open protocol
+ Expand
5

Affymetrix SNP 6.0 Array Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA from tumor and peripheral blood was processed using Affymetrix Genome-Wide Human SNP 6.0 (Affymetrix, CA, USA) according to manufacturer’s protocols. Briefly, DNA was digested with NspI and StyI enzymes (New England Biolabs, USA), ligated to the respective Affymetrix adapters using T4 DNA ligase (New England Biolabs, USA) amplified (Clontech-Takara Bio, USA), purified using magnetic beads (Agencourt, Beckman, USA), labeled, fragmented, and hybridized to the arrays. Following hybridization, the arrays were washed and stained with streptavidin-phycoerythrin (Invitrogen, USA). Arrays preparation and scanning was performed at the genotyping core laboratory of INMEGEN. Background correction and extraction of raw fluorescence intensity were performed with the Affymetrix Genotyping Console. Raw microarray data was deposited in GEO under the number GSE87048.
+ Open protocol
+ Expand
6

Copy Number Variation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intensity (*.CEL) files of 222 individuals from the above QC protocol were extracted for copy number analysis using Affymetrix® Genotyping Console. Copy number segments were filtered to regions (minimum genomic size of 2 kbps) with 10 marker per segment [26 ]. The copy number data was exported as tab-delimited file for copy number association in CNVRuler [27 (link)]. CNV regions were significantly associated at FDR p-value < 0.05. The significant CNV regions were visualized using Phenogram [28 (link)] then mapped to genes using UCSC browser for GRCh37/hg19 assembly (https://genome.ucsc.edu/). The genes within CNV regions were analyzed for functional and diseases processes and visualized using Ingenuity Pathway Analysis (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis).
+ Open protocol
+ Expand
7

Integrated DNA Copy Number and Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
DLBCL DNA samples were analyzed with the Affymetrix SNP6.0 array. Probe log ratios were calculated using Affymetrix Genotyping Console, and were collected into segments of similar value using circular binary segmentation (http://www.bioconductor.org/packages/3.7/bioc/manuals/DNAcopy/man/DNAcopy.pdf). These segments were assigned copy number values as previously described 33 (link) without segment length restrictions. DNA copy number was correlated to sample gene expression using linear regressions calculated with Graphpad Prism version 7.0. Amplified regions were identified and visualized on the UCSC genome browser, Hg19.
+ Open protocol
+ Expand
8

Genetic Analysis of CERS2 Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA samples were typed for 1.8 million probe sets on the Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA). CNV (copy number variation) analysis was performed by the algorithm implemented in the Affymetrix Genotyping Console version 4.0. (Affymetrix, Santa Clara, CA). The presumed pathogenic CNV was verified in the index patient, and also tested in the parents with TaqMan qPCR (Life Technologies, Carlsbad, CA) according to manufacturer's instructions. Seven specific primer pairs were designed to amplify the 10 coding exons of CERS2 and the adjacent intron-exon boundaries. PCR amplicons were sequenced using Applied BiosystemsTM according to the supplier's recommendations. Paternity was confirmed by genotyping 15 short tandem repeat (STR) markers located on 10 different chromosomes.
+ Open protocol
+ Expand
9

SNP Microarray Analysis of Chromosomal Aberrations

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNP microarray analysis was used to determine chromosomal aberrations. Two types of SNP microarray chips were used, the Affymetrix 250K_NSP-chip, with ~250,000 probes across the genome and the Affymetrix Cytoscan HD chip, with ~750,000. The first 28 samples were analyzed with the Affymetrix 250K_NSP chip, and the remaining 36 samples with the Affymetrix Cytoscan HD chip. Analysis of the Affymetrix 250K_NSP chips was performed with the ‘Genotyping Console’ to determine the copy number values and the ‘GCT Browser’ to visualize the data (both from Affymetrix, Santa Clara, USA). Affymetrix Cytoscan HD chips were analyzed with ‘ChAS’. Different loci per chromosome were evaluated to adjust for partial gains or deletions. ~200 probes per gene locus were averaged to determine eventual copy number.
+ Open protocol
+ Expand
10

Profiling mRNA Expression Changes after S6K1/S6K2 Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Affymetrix GeneChip Gene 2.0 expression arrays (Affymetrix) were used to profile alterations in global mRNA expression after silencing of S6K1, S6K2 or S6K1+S6K2 in triplicates. The assay was performed according to manufacturer’s protocols with 250 ng total RNA as starting material. Briefly, RNA was reverse transcribed into first and second strand cDNA, thereafter converted to cRNA and finally sscDNA, using Ambion, Life Technologies, WT Expression Kit (Ambion, Life Technologies). The sscDNA was fragmented and labelled with GeneChip WT Terminal labelling and hybridisation kit (Affymetrix), and hybridised to the arrays. Affymetrix Scanner 3000 7G was used to scan the arrays and generated data were converted to cell intensity files in Affymetrix Genotyping Console. Cell intensity data were processed by the software Genespring (Agilent Technologies). Raw data was normalised to the median of the control samples using the Robust Multi-array Average (RMA) summarisation algorithm [28 (link)]. Paired two-sided t-tests were used to estimate significant differences in gene expression after downregulation of S6K1 and/or S6K2 in comparison to scrambled siRNA. Only results from annotated genes were reported. As a significance limit p<0.05 was used.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!